Alaethes Wealth’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Alaethes Wealth's LLY Position: Q1 2026 in Review
Alaethes Wealth reduced its Eli Lilly (LLY) stake by 0.12% in Q1 2026, selling an estimated $5.07K and leaving 4,276 shares worth $3.93M. The position accounts for 1.12% of the portfolio, ranked #20.
Alaethes Wealth first reported a position in LLY in Q1 2021 and has held it in 21 quarters since. The position peaked at $4.6M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Alaethes Wealth held 4,276 shares of Eli Lilly worth $3.93M as of Q1 2026.
- Alaethes Wealth sold 5 Eli Lilly shares in Q1 2026, an estimated $5.07K.
- Eli Lilly made up 1.12% of Alaethes Wealth's portfolio in Q1 2026, its #20 holding.
- Alaethes Wealth first reported a position in Eli Lilly in Q1 2021 and has held it in 21 quarters since.
- Alaethes Wealth's Eli Lilly position peaked at $4.6M in Q4 2025.
- 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Alaethes Wealth's 13F filing for Q1 2026, filed 12 May 2026.